Jiangxi Sets Sail, HongKong Rings the Bell: The Celebration of JIANGXI BIO’s Listing on the Main Board of the Hong Kong Stock Exchange Concludes Successfully

At 9:30 a.m. on June 30, Jiangxi Institute of Biological Products Co., Ltd. (“the Company”) (stock code: 6915.HK) officially listed on the Main Board of the Hong Kong Stock Exchange, marking a successful debut. On the same day, the Company held a grand exclusive appreciation ceremony for its Hong Kong stock listing in Shenzhen, attended by a distinguished gathering and celebrated with remarkable splendor. Guests from all sectors came together to commemorate this momentous occasion and embark on a new chapter. 

That morning, the company’s listing ceremony on the Hong Kong Stock Exchange was held with great solemnity. Representing the company, Chairwoman Jing Yue and Co‑founder Mr. Jing Wei rang the opening bell, while the core management team, family and friends, shareholder representatives, and institutional guests took to the stage together, successfully concluding the listing on the Main Board of the Hong Kong Stock Exchange. This milestone marks Jiangxi Bio’s official entry into the Hong Kong capital market, ushering in a new phase of internationalization, standardization, and high‑quality development. As an industry leader that has maintained the top position in China’s human tetanus antitoxin market for 19 consecutive years, with products exported to more than 30 countries and regions worldwide, Jiangxi Bio will build on its strong local industrial roots in Jiangxi and leverage Hong Kong’s international financial platform to accelerate its corporate capital strategy, drive scientific research and innovation, and expand its market reach—propelling the company to unprecedented heights.

As night fell along the banks of the Pearl River, the company’s grand thank-you gala marking its Shenzhen stock market listing commenced as scheduled. Leaders from governments at all levels, representatives of financial investment institutions, sponsoring teams from securities firms, upstream and downstream industry partners, industry guests, and the company’s entire core leadership team gathered on site, creating an atmosphere that was both solemn and enthusiastic, warm and thoroughly successful.

At the outset of the gala, the host delivered a solemn address, reflecting on the company’s decades-long journey of dedicated cultivation in the biopharmaceutical sector. The speaker expressed heartfelt gratitude for the support of government agencies at all levels, the trust of our partners, and the unwavering commitment of every colleague, while celebrating the milestone of the company’s successful listing on the Hong Kong Stock Exchange.

Subsequently, the company’s chairman took the stage to deliver a heartfelt address, reflecting on the warm journey of shared dedication and mutual support. He outlined the company’s long-term strategic plans for future R&D investment, industrial expansion, and coordinated development across the Guangdong–Hong Kong–Macao Greater Bay Area and Jiangxi Province. He solemnly pledged that, with an IPO as a new starting point, the company will steadfastly uphold compliant operations, deepen its commitment to technological innovation and public health, and deliver outstanding performance to give back to society, reward shareholders, and honor all its partners.

On-site government and enterprise representatives, along with institutional guests, took turns delivering remarks, warmly commending Jiangxi’s strengths in biotechnology innovation and the sector’s promising prospects. They discussed a vision for deepened collaboration between Jiangxi and Shenzhen, synergistic development within the Guangdong–Hong Kong–Macao Greater Bay Area, and long-term partnerships in the biopharmaceutical industry, earning sustained applause and widespread consensus. 
At the gala, representatives of the Southern University of Science and Technology Business School’s Alumni Association of Technology Management scholars were also invited to attend, exchanging commemorative gifts with the company to celebrate a momentous occasion: Jiangxi Bio has become the first alumni‑affiliated enterprise to successfully list on the Hong Kong Stock Exchange since the association’s founding. This “first” honor serves as a vivid testament to the synergy between the university and industry, as well as to the power of resource integration. 
During the gala, hosts and guests gathered in warm camaraderie, engaging in heartfelt exchanges and toasting one another, jointly celebrating the successful IPO and wishing the company enduring prosperity, the stock market continued strength, and steady progress toward long-term success. The entire evening unfolded with seamless organization and a vibrant atmosphere, marked by deep bonds of friendship and an overall sense of harmony and fulfillment, drawing to a close amid laughter and hopeful aspirations. 
The Gan River flows on to join the Pearl River, and together they usher in a new chapter for the Greater Bay Area. The Hong Kong Stock Exchange listing ceremony and the Shenzhen‑specific appreciation banquet were conducted with solemnity and order, concluding smoothly and successfully. They not only captured the company’s moment of glory but also rallied the concerted efforts of all sectors, laying a solid foundation for Jiangxi Bio’s long‑term global expansion.